FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Barry Gidal

Research Profile

Chemicals & Drugs

Disorders

Physiology

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Ashley E Feldman; Barry E Gidal
QTc prolongation by antiepileptic drugs and the risk of torsade de pointes in patients with epilepsy.
Martin J Brodie; Barry E Gidal; Scott Mintzer; Alison M Pack; Charles J Vecht; Dieter Schmidt
Enzyme induction with antiepileptic drugs: cause for concern?
M K Heim; Barry E Gidal
Vigabatrin-associated retinal damage: potential biochemical mechanisms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Barry Gidal (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ashley E Feldman; Barry E Gidal
QTc prolongation by antiepileptic drugs and the risk of torsade de pointes in patients with epilepsy.
Epilepsy & behavior : E&B 2013;26(3):421-6.
2013: Martin J Brodie; Barry E Gidal; Scott Mintzer; Alison M Pack; Charles J Vecht; Dieter Schmidt
Enzyme induction with antiepileptic drugs: cause for concern?
Epilepsia 2013;54(1):11-27.
2012: M K Heim; Barry E Gidal
Vigabatrin-associated retinal damage: potential biochemical mechanisms.
Acta neurologica Scandinavica 2012;126(4):219-28.
2012: Barry E Gidal
Generic antiepileptic drugs: how good is close enough?
Epilepsy currents / American Epilepsy Society 2012;12(1):32-4.
2011: Barry E Gidal
Carbamazepine hypersensitivity: progress toward predicting the unpredictable.
Epilepsy currents / American Epilepsy Society 2011;11(6):189-91.
2010: Sean D Candrilli; Ranjani Manjunath; Keith L Davis; Barry E Gidal
The association between antiepileptic drug and HMG-CoA reductase inhibitor co-medication and cholesterol management in patients with epilepsy.
Epilepsy research 2010;91(2-3):260-6.
2010: Barry E Gidal
Pharmacokinetic interactions with antiepileptic drugs: always the bad actor or simply misunderstood?
Epilepsy currents / American Epilepsy Society 2010;10(5):113-5.
2009: Erin E Mancl; Barry E Gidal
The effect of carbapenem antibiotics on plasma concentrations of valproic acid.
The Annals of pharmacotherapy 2009;43(12):2082-7.
2009: Cynthia Harden; Jennifer L Hopp; Tricia Y Ting; Page B Pennell; J A French; W A Hauser; Samuel Wiebe; Gary S Gronseth; D Thurman; Kimford J Meador; B S Koppel; Peter W Kaplan; J N Robinson; Barry E Gidal; Collin A Hovinga; A N Wilner; B Vazquez; L Holmes; Allan Krumholz; Richard Finnell; C Le Guen
Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
Neurology 2009;73(2):126-32.
2009: Cynthia Harden; Kimford J Meador; Page B Pennell; W A Hauser; Gary S Gronseth; J A French; Samuel Wiebe; D Thurman; B S Koppel; Peter W Kaplan; J N Robinson; Jennifer L Hopp; Tricia Y Ting; Barry E Gidal; Collin A Hovinga; A N Wilner; B Vazquez; L Holmes; Allan Krumholz; Richard Finnell; D Hirtz; C Le Guen
Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
Neurology 2009;73(2):133-41.
2009: Cynthia Harden; Page B Pennell; B S Koppel; Collin A Hovinga; Barry E Gidal; Kimford J Meador; Jennifer L Hopp; Tricia Y Ting; W A Hauser; D Thurman; Peter W Kaplan; J N Robinson; J A French; Samuel Wiebe; A N Wilner; B Vazquez; L Holmes; Allan Krumholz; Richard Finnell; P O Shafer; C Le Guen
Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society.
Neurology 2009;73(2):142-9.
2009: Barry E Gidal
Bioequivalence of antiepileptic drugs: how close is close enough?
Current neurology and neuroscience reports 2009;9(4):333-7.
2009: Cynthia Harden; Page B Pennell; Barbara S Koppel; Collin A Hovinga; Barry E Gidal; Kimford J Meador; Jennifer L Hopp; Tricia Y Ting; W A Hauser; David Thurman; Peter W Kaplan; Julian N Robinson; Jacqueline A French; Samuel Wiebe; Andrew N Wilner; Blanca Vazquez; Lewis Holmes; Allan Krumholz; Richard Finnell; Patricia O Shafer; Claire L Le Guen
Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Epilepsia 2009;50(5):1247-55.
2009: Cynthia Harden; Kimford J Meador; Page B Pennell; W Allen Hauser; Gary S Gronseth; Jacqueline A French; Samuel Wiebe; David Thurman; Barbara S Koppel; Peter W Kaplan; Julian N Robinson; Jennifer L Hopp; Tricia Y Ting; Barry E Gidal; Collin A Hovinga; Andrew N Wilner; Blanca Vazquez; Lewis Holmes; Allan Krumholz; Richard Finnell; Deborah Hirtz; Claire Le Guen
Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Epilepsia 2009;50(5):1237-46.
2009: Cynthia Harden; Jennifer L Hopp; Tricia Y Ting; Page B Pennell; Jacqueline A French; W Allen Hauser; Samuel Wiebe; Gary S Gronseth; David Thurman; Kimford J Meador; Barbara S Koppel; Peter W Kaplan; Julian N Robinson; Barry E Gidal; Collin A Hovinga; Andrew N Wilner; Blanca Vazquez; Lewis Holmes; Allan Krumholz; Richard Finnell; Claire Le Guen
Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Epilepsia 2009;50(5):1229-36.
2009: Barry E Gidal; Jacqueline A French; Patricia Grossman; Gwénaël Le Teuff
Assessment of potential drug interactions in patients with epilepsy: impact of age and sex.
Neurology 2009;72(5):419-25.
2008: Bruce Hermann; Michael Seidenberg; Mark A Sager; Cynthia Carlsson; Barry E Gidal; Raj Sheth; Paul Rutecki; Sanjay Asthana
Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy.
Epilepsia 2008;49(5):731-40.
2008: Andres M Kanner; Barry E Gidal
Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
International review of neurobiology 2008;83():397-416.
2008: Barry E Gidal; Cynthia Harden
Epilepsy in women.
International review of neurobiology 2008;83():xvii-xviii.
2007: Page B Pennell; Barry E Gidal; Anne Sabers; Jacki Gordon; Emilio Perucca
Pharmacology of antiepileptic drugs during pregnancy and lactation.
Epilepsy & behavior : E&B 2007;11(3):263-9.
2007: Erik St. Louis; Barry E Gidal; Thomas R Henry; Yevgenya Jane Kaydanova; Allan Krumholz; Paul H McCabe; Georgia Montouris; William E Rosenfeld; Brien J Smith; John M Stern; Elizabeth J Waterhouse; Richard M Schulz; William R Garnett; Thomas Bramley
Conversions between monotherapies in epilepsy: expert consensus.
Epilepsy & behavior : E&B 2007;11(2):222-34.
2007: Barry E Gidal
Antiepileptic drug formulation and treatment in the elderly: biopharmaceutical considerations.
International review of neurobiology 2007;81():299-311.
2006: Raj D Sheth; Barry E Gidal; Bruce P Hermann
Pathological fractures in epilepsy.
Epilepsy & behavior : E&B 2006;9(4):601-5.
2006: Barry E Gidal; John J Barry
Sexual dysfunction in patients with neuropsychiatric disorders: Challenges and opportunities.
CNS spectrums 2006;11(8 Suppl 9):4-5.
2006: Barry E Gidal
New and emerging treatment options for neuropathic pain.
The American journal of managed care 2006;12(9 Suppl):S269-78.
2006: Raj D Sheth; Barry E Gidal
Optimizing epilepsy management in teenagers.
Journal of child neurology 2006;21(4):273-9.
2006: Raj D Sheth; Joseph F Drazkowski; Joseph I Sirven; Barry E Gidal; Bruce P Hermann
Protracted ictal confusion in elderly patients.
Archives of neurology 2006;63(4):529-32.
2006: Barry E Gidal
Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs.
Epilepsy research 2006;68 Suppl 1():S65-9.
2005: Sebastian Koch; Barry E Gidal
Phenytoin and cognitive decline.
Stroke; a journal of cerebral circulation 2005;36(10):2070-1; author reply 2071.
2005: Monica A Fay; Raj D Sheth; Barry E Gidal
Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
Clinical therapeutics 2005;27(5):594-8.
2005: Barry E Gidal; T Tamura; Anne Hammer; Alain Vuong
Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy.
Epilepsy research 2005;64(3):161-6.
2005: Barry E Gidal; Eugène Baltès; Christian Otoul; Emilio Perucca
Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.
Epilepsy research 2005;64(1-2):1-11.
2005: Rama Maganti; Raj D Sheth; Bruce P Hermann; Steven Weber; Barry E Gidal; Jason P Fine
Sleep architecture in children with idiopathic generalized epilepsy.
Epilepsia 2005;46(1):104-9.
2004: Ilo E Leppik; Gregory K Bergey; R Eugene Ramsay; A James Rowan; Barry E Gidal; Angela K Birnbaum; Mary Beth Elliott
Advances in antiepileptic drug treatments. A rational basis for selecting drugs for older patients with epilepsy.
Geriatrics 2004;59(12):14-8, 22-4.
2004: Robert A Gross; Barry E Gidal; Alison M Pack
Patient page. Antiseizure drugs and reduced bone density.
Neurology 2004;62(11):E24-5.
2004: Jacqueline A French; Andres M Kanner; Jocelyn Bautista; Bassel Abou-Khalil; Thomas Browne; Cynthia Harden; William H Theodore; Carl W Bazil; John Stern; Steven C Schachter; Donna C Bergen; Deborah Hirtz; Georgia Montouris; Mark Nespeca; Barry E Gidal; William J Marks; William R Turk; James H Fischer; Blaise Bourgeois; Andrew Wilner; R Edward Faught; Rajesh C Sachdeo; Ahmad Beydoun; Tracy A Glauser
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
Epilepsia 2004;45(5):410-23.
2004: Jacqueline A French; Andres M Kanner; Jocelyn Bautista; Bassel Abou-Khalil; Thomas Browne; Cynthia Harden; William H Theodore; Carl W Bazil; John Stern; Steven C Schachter; Donna C Bergen; Deborah Hirtz; Georgia Montouris; Mark Nespeca; Barry E Gidal; William J Marks; William R Turk; James H Fischer; Blaise Bourgeois; Andrew Wilner; R Edward Faught; Rajesh C Sachdeo; Ahmad Beydoun; Tracy A Glauser
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
Epilepsia 2004;45(5):401-9.
2004: Jacqueline A French; Andres M Kanner; Jocelyn Bautista; Bassel Abou-Khalil; Thomas Browne; Cynthia Harden; William H Theodore; Carl W Bazil; John Stern; Steven C Schachter; Donna C Bergen; Deborah Hirtz; Georgia Montouris; Mark Nespeca; Barry E Gidal; William J Marks; William R Turk; James H Fischer; Blaise Bourgeois; Andrew Wilner; R Edward Faught; Rajesh C Sachdeo; Ahmad Beydoun; Tracy A Glauser
Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Neurology 2004;62(8):1261-73.
2004: Jacqueline A French; Andres M Kanner; Jocelyn Bautista; Bassel Abou-Khalil; Thomas Browne; Cynthia Harden; William H Theodore; Carl W Bazil; John Stern; Steven C Schachter; Donna C Bergen; Deborah Hirtz; Georgia Montouris; Mark Nespeca; Barry E Gidal; William J Marks; William R Turk; James H Fischer; Blaise Bourgeois; Andrew Wilner; R Edward Faught; Rajesh C Sachdeo; Ahmad Beydoun; Tracy A Glauser
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
Neurology 2004;62(8):1252-60.
2004: Alison M Pack; Barry E Gidal; Blanca Vazquez
Bone disease associated with antiepileptic drugs.
Cleveland Clinic journal of medicine 2004;71 Suppl 2():S42-8.
2004: Richard H Mattson; Barry E Gidal
Fractures, epilepsy, and antiepileptic drugs.
Epilepsy & behavior : E&B 2004;5 Suppl 2():S36-40.
2003: Barry E Gidal; Raj Sheth; Jennifer Parnell; Kathy Maloney; Mark Sale
Evaluation of VPA dose and concentration effects on lamotrigine pharmacokinetics: implications for conversion to lamotrigine monotherapy.
Epilepsy research 2003;57(2-3):85-93.
2003: Barry E Gidal; Raj D Sheth; Leslie Magnus; Anne-Francoise Herbeuval
Levetiracetam does not alter body weight: analysis of randomized, controlled clinical trials.
Epilepsy research 2003;56(2-3):121-6.
2003: Michael J McLean; Barry E Gidal
Gabapentin dosing in the treatment of epilepsy.
Clinical therapeutics 2003;25(5):1382-406.
2003: Emilio Perucca; Barry E Gidal; Eugène Baltès
Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials.
Epilepsy research 2003;53(1-2):47-56.
2002: Barry E Gidal; Christopher P Nemergut; Jacqueline A French
Drug interactions in epilepsy care: perspective on the newer generation antiepileptic drugs.
Expert review of neurotherapeutics 2002;2(6):801-8.
2002: Gail D Anderson; Barry E Gidal; John A Messenheimer; Frank G Gilliam
Time course of lamotrigine de-induction: impact of step-wise withdrawal of carbamazepine or phenytoin.
Epilepsy research 2002;49(3):211-7.
2002: Timothy E Welty; Barry E Gidal; David M Ficker; Michael D Privitera
Levetiracetam: a different approach to the pharmacotherapy of epilepsy.
The Annals of pharmacotherapy 2002;36(2):296-304.
2001: I E Leppik; J A French; Gregory K Bergey; Barry E Gidal; S Abu-Samrah; D B Cooper; D M Franey; R W Jones; L Tamsky; A Wright
Managing healthcare resources appropriately. Roundtable discussion.
The American journal of managed care 2001;7(7 Suppl):S227-34.
2001: Flavia M Pryor; Barry E Gidal; R Eugene Ramsay; John C DeToledo; R O Morgan
Fosphenytoin: pharmacokinetics and tolerance of intramuscular loading doses.
Epilepsia 2001;42(2):245-50.
2000: Barry E Gidal; G D Anderson; P R Rutecki; R Shaw; A Lanning
Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy.
Epilepsy research 2000;42(1):23-31.
2000: Raj D Sheth; Bruce P Hermann; H Rowley; Barry E Gidal; V M Haughton; Brian D Bell; Austin Woodard
Pediatric epilepsy surgery: neuroimaging, neuropsychology, and anticonvulsants.
Seminars in pediatric neurology 2000;7(3):166-77.
2000: Barry E Gidal; L L Radulovic; S Kruger; Paul Rutecki; ME Pitterle; HN Bockbrader
Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability.
Epilepsy research 2000;40(2-3):123-7.
2000: M A Laird; Barry E Gidal
Use of gabapentin in the treatment of neuropathic pain.
The Annals of pharmacotherapy 2000;34(6):802-7.
2000: Raj D Sheth; Barry E Gidal
Intravenous valproic acid for myoclonic status epilepticus.
Neurology 2000;54(5):1201.
2000: Jacqueline A French; Barry E Gidal
Antiepileptic drug interactions.
Epilepsia 2000;41 Suppl 8():S30-6.
1999: Patrick Meek; S N Davis; D M Collins; Barry E Gidal; Paul Rutecki; A H Burstein; James H Fischer; Ilo E Leppik; R Eugene Ramsay
Guidelines for nonemergency use of parenteral phenytoin products: proceedings of an expert panel consensus process. Panel on Nonemergency Use of Parenteral Phenytoin Products.
Archives of internal medicine 1999;159(22):2639-44.
1999: Barry E Gidal; Michael D Privitera; R D Sheth; J T Gilman
Vigabatrin: a novel therapy for seizure disorders.
The Annals of pharmacotherapy 1999;33(12):1277-86.
1999: Barry E Gidal; Gary L Lensmeyer
Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography method.
Therapeutic drug monitoring 1999;21(5):567-76.
1999: Barry E Gidal; J N Seltz; Paul Rutecki
A 13-year-old with an acute change in mental status.
Seminars in pediatric neurology 1999;6(3):146-9; discussion 149-50.
1999: Mark S Luer; C Hamani; Manuel Dujovny; Barry E Gidal; Michael Cwik; Kelly Deyo; James H Fischer
Saturable transport of gabapentin at the blood-brain barrier.
Neurological research 1999;21(6):559-62.
1999: Pamela S Wiegartz; Michael Seidenberg; Austin Woodard; Barry E Gidal; Bruce Hermann
Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression.
Neurology 1999;53(5 Suppl 2):S3-8.
1999: M Collins; Barry E Gidal; W R Garnett; G Reinfeldt; G M Tusch
Potential underreporting of intravenous phenytoin adverse events.
The Annals of pharmacotherapy 1999;33(1):111-2.
1998: Raj D Sheth; Barry E Gidal
Refractory status epilepticus: response to ketamine.
Neurology 1998;51(6):1765-6.
1998: N M Graves; Barry E Gidal; F G Gilliam
The new generation of antiepileptic drugs: unresolved questions.
The Annals of pharmacotherapy 1998;32(11):1239-43.
1998: Barry E Gidal; J DeCerce; HN Bockbrader; J Gonzalez; S Kruger; ME Pitterle; Paul Rutecki; R Eugene Ramsay
Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy.
Epilepsy research 1998;31(2):91-9.
1998: Barry E Gidal; MM Maly; J W Kowalski; Paul Rutecki; ME Pitterle; D E Cook
Gabapentin absorption: effect of mixing with foods of varying macronutrient composition.
The Annals of pharmacotherapy 1998;32(4):405-9.
1997: Barry E Gidal; Paul Rutecki; R Shaw; MM Maly; D M Collins; ME Pitterle
Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy.
Epilepsy research 1997;28(3):207-11.
1997: Gary L Lensmeyer; Barry E Gidal; D A Wiebe
Optimized high-performance liquid chromatographic method for determination of lamotrigine in serum with concomitant determination of phenytoin, carbamazepine, and carbamazepine epoxide.
Therapeutic drug monitoring 1997;19(3):292-300.
1997: Barry E Gidal; C M Inglese; J F Meyer; ME Pitterle; J Antonopolous; R S Rust
Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine.
Pediatric neurology 1997;16(4):301-5.
1997: Barry E Gidal; A Kanner; MM Maly; Paul Rutecki; Gary L Lensmeyer
Lamotrigine pharmacokinetics in patients receiving felbamate.
Epilepsy research 1997;27(1):1-5.
1997: Barry E Gidal; T E Welty
The concentration-effect relationship with lamotrigine (LTG)
Epilepsia 1997;38(2):260.
1996: Barry E Gidal; M L Crismon; M L Wagner; Susan C Fagan; M D Privitera; C Dalmady-Israel; N M Graves
Current developments in neurology, Part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and stroke.
The Annals of pharmacotherapy 1996;30(12):1446-51.
1996: A T Mailloux; Barry E Gidal; C A Sorkness
Potential interaction between warfarin and dicloxacillin.
The Annals of pharmacotherapy 1996;30(12):1402-7.
1996: Barry E Gidal; M L Wagner; M D Privitera; C Dalmady-Israel; M L Crismon; Susan C Fagan; N M Graves
Current developments in neurology, Part I: Advances in the pharmacotherapy of headache, epilepsy, and multiple sclerosis.
The Annals of pharmacotherapy 1996;30(11):1272-6.
1996: Barry E Gidal; W G Reiss; J S Liao; M E Pitterle
Changes in interleukin-6 concentrations following epilepsy surgery: potential influence on carbamazepine pharmacokinetics.
The Annals of pharmacotherapy 1996;30(5):545-6.
1996: Barry E Gidal; N W Spencer; M M Maly; M E Pitterle
Evaluation of carbamazepine and carbamazepine-epoxide protein binding in patients undergoing epilepsy surgery.
Epilepsia 1996;37(4):381-5.
1996: Barry E Gidal; M M Maly; J Budde; Gary L Lensmeyer; M E Pitterle; J C Jones
Effect of a high-protein meal on gabapentin pharmacokinetics.
Epilepsy research 1996;23(1):71-6.
1995: Barry E Gidal; M M Maly; R E Nemire; K Haley
Weight gain and gabapentin therapy.
The Annals of pharmacotherapy 1995;29(10):1048.
1995: L M Holle; Barry E Gidal; D M Collins
Valproate in status epilepticus.
The Annals of pharmacotherapy 1995;29(10):1042-4.
1995: Barry E Gidal; M E Pitterle; N W Spencer; M M Maly
Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy.
Journal of clinical pharmacy and therapeutics 1995;20(4):215-9.
1995: Gary L Lensmeyer; T Kempf; Barry E Gidal; D A Wiebe
Optimized method for determination of gabapentin in serum by high-performance liquid chromatography.
Therapeutic drug monitoring 1995;17(3):251-8.
1995: Barry E Gidal; C A Sorkness; KA McGill; R Larson; R R Levine
Evaluation of a potential enantioselective interaction between ticlopidine and warfarin in chronically anticoagulated patients.
Therapeutic drug monitoring 1995;17(1):33-8.
1994: Barry E Gidal; N Spencer; M Maly; M Pitterle; E Williams; M Collins; J Jones
Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
Neurology 1994;44(8):1418-22.
1993: D M Collins; Barry E Gidal; M E Pitterle
Potential interaction between carbamazepine and loxapine: case report and retrospective review.
The Annals of pharmacotherapy 1993;27(10):1180-7.
1993: Barry E Gidal; D M Collins; B R Beinlich
Apparent valproic acid neurotoxicity in a hypoalbuminemic patient.
The Annals of pharmacotherapy 1993;27(1):32-5.